Pneumatosis cystoides intestinalis (PCI) in a patient with undiagnosed systemic sclerosis

Abstract

Pneumatosis cystoides intestinalis (PCI) refers to the presence of gas within the wall of the small or large intestine. The pathophysiology is incompletely understood and is probably multifactorial in nature. PCI is a known but rare complication of systemic scleroderma, and the aetiology of PCI in patients with scleroderma is not fully understood. We present the case of a patient who was referred to gastroenterology clinic by her general practitioner for investigation of 8 months of weight loss, urgency, diarrhoea, bloating and crampy abdominal pain. Extensive investigations were performed to exclude infective, inflammatory or malignant aetiologies for these symptoms. She was diagnosed with PCI on her colonoscopy and was subsequently screened for secondary causes. Our patient was diagnosed with the limited cutaneous (CREST) variant of systemic scleroderma. This case report illustrates that PCI could be an uncommon presentation of systemic sclerosis, therefore clinicians should be aware of the association between these conditions.

“Cystamatic” Review: Is Surgery Mandatory for Pneumatosis Cystoides Intestinalis?

“…The principal symptom was abdominal pain associated with the finding of free air under diaphragm. These [12] 65 years, M Secondary Intake of α-glucosidase inhibitors Takahashi et al [13] 17 years, F Idiopathic -Singh et al [14] N/A, F Secondary Systemic sclerosis Asahi et al [15] 67 years, M Secondary Neoplasm Uruga et al [16] 71 years, F Secondary Neoplasm Koysombat et al [17] N/A Secondary Systemic sclerosis Wang et al [18] 56 years, M Idiopathic -48 years, F Secondary Exposing to trichloroethylene 66 years, F Secondary Disease of immune system 72 years, F Secondary Diabetes 64 years, M Secondary Emphysema 24 years, F Secondary Neoplasm Martin-Lagos et al [19] 72 years, M Secondary Chemotherapy Suda et al [20] 80 years, M Idiopathic -Márquez Argente et al [21] 48 years, M Idiopathic de la Serna et al [22] 83 years, M Secondary Chemotherapy Mikami et al [23] 72 years, M Secondary Ulcerative colitis Sugihara et al [24] 48 years, F Secondary Therapy with glucocorticoid Kunishi et al [25] 84 years, M Secondary Intake of α-glucosidase inhibitors Lee et al [26] 68 years, F Secondary Chemotherapy Kang et al [27] 54 years, M Secondary COPD Nakatani et al [28] 70 years, M Secondary Granulomatosis with polyangiitis Rachapalli et al [29] 50 years, M Secondary Neoplasm Jegadeesan et al [30] 51 years, M Secondary Neoplasm Liao et al [31] 84 years, F Idiopathic -Suzuki et al [32] 71 years, F Secondary Connective tissue disease 70 years, F Secondary Connective tissue disease 70 years, M Secondary Connective tissue disease 42 years, F Secondary Connective tissue disease Iida et al [33] 79 years, M Secondary COPD Romano-Munive et al [34] 54 years, F Idiopathic -Venkataramani et al [35] 56 years, F Secondary Neoplasm Faria et al [36] 69 years, M Secondary Neoplasm Fujimi et al [37] 55 years, M Secondary Interstitial pneumonia with corticosteroid therapy Furihata et al [38] 81 years, M Idiopathic -Mima et al [39] 46 years, M Secondary Rheumatoid arthritis Torigoe et al [40] 77 ...…”